Based on analysts offering 12 month price targets for GPP in the last 3 months. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Sign in to your ...

The study included 2630 patients with GPP (1,246 GPP-only and 1,384 GPP + PsO), 127,540 patients with plaque PsO, and over 19.6 million individuals from the general population.

Spesolimab, a monoclonal antibody that blocks interleukin (IL)-36 signaling known to be involved in GPP, was first approved by the US Food and Drug Administration in 2022 for treating flares in ...

Lite-On Semiconductor, a maker of discrete and analog IC components, has been ramping up shipments of its GPP (glass passivated package) diodes to the smartphone sector in China, driving revenue ...

In the phase 2b study, patients who received the high-dose regimen (a 600-mg subcutaneous [SC] loading dose, then 300-mg SC every 4 weeks) of spesolimab experienced 84% fewer GPP fares over 48 ...